Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 108 entries
Sorted by: Best Match Show Resources per page
Surgical Management of Compound Odontoma Associated with Unerupted Tooth.

Case reports in dentistry

Pacifici A, Carbone D, Marini R, Pacifici L.
PMID: 26199762
Case Rep Dent. 2015;2015:902618. doi: 10.1155/2015/902618. Epub 2015 Jun 25.

Odontomas represent the most common type of odontogenic benign jaws tumors among patients younger than 20 years of age. These tumors are composed of enamel, dentine, cementum, and pulp tissue. According to the World Health Organization classification, two distinct...

Cite
Pacifici A, Carbone D, Marini R, et al. Surgical Management of Compound Odontoma Associated with Unerupted Tooth. Case Rep Dent. 2015;2015:902618doi: 10.1155/2015/902618.
Pacifici, A., Carbone, D., Marini, R., & Pacifici, L. (2015). Surgical Management of Compound Odontoma Associated with Unerupted Tooth. Case reports in dentistry, 2015902618. https://doi.org/10.1155/2015/902618
Pacifici, Andrea, et al. "Surgical Management of Compound Odontoma Associated with Unerupted Tooth." Case reports in dentistry vol. 2015 (2015): 902618. doi: https://doi.org/10.1155/2015/902618
Pacifici A, Carbone D, Marini R, Pacifici L. Surgical Management of Compound Odontoma Associated with Unerupted Tooth. Case Rep Dent. 2015;2015:902618. doi: 10.1155/2015/902618. Epub 2015 Jun 25. PMID: 26199762; PMCID: PMC4496474.
Copy Download .nbib Format: NLM
The Never-Ending Public Health Issue of Adulterants in Abused Drugs.

Journal of analytical toxicology

Busardò FP, Pichini S, Pacifici R, Karch SB.
PMID: 27368339
J Anal Toxicol. 2016 Sep;40(7):561-2. doi: 10.1093/jat/bkw051. Epub 2016 Jun 30.

No abstract available.

Cite
Busardò FP, Pichini S, Pacifici R, et al. The Never-Ending Public Health Issue of Adulterants in Abused Drugs. J Anal Toxicol. 2016;40(7):561-2doi: 10.1093/jat/bkw051.
Busardò, F. P., Pichini, S., Pacifici, R., & Karch, S. B. (2016). The Never-Ending Public Health Issue of Adulterants in Abused Drugs. Journal of analytical toxicology, 40(7), 561-2. https://doi.org/10.1093/jat/bkw051
Busardò, Francesco P, et al. "The Never-Ending Public Health Issue of Adulterants in Abused Drugs." Journal of analytical toxicology vol. 40,7 (2016): 561-2. doi: https://doi.org/10.1093/jat/bkw051
Busardò FP, Pichini S, Pacifici R, Karch SB. The Never-Ending Public Health Issue of Adulterants in Abused Drugs. J Anal Toxicol. 2016 Sep;40(7):561-2. doi: 10.1093/jat/bkw051. Epub 2016 Jun 30. PMID: 27368339.
Copy Download .nbib Format: NLM
Efficacy of Blended Preservice Training for Resource Parents.

Child welfare

White L, Delaney R, Pacifici C, Nelson C, Whitkin J, Lovejoy M, Smalley BK.
PMID: 28626240
Child Welfare. 2014 Nov-Dec;93(6):45-72.

To evaluate a new way of meeting the growing demand for training prospective resource parents, our study compared the efficacy of a blended online and in-person approach with a traditional classroom-only approach. Findings based on a sample of 111...

Cite
White L, Delaney R, Pacifici C, et al. Efficacy of Blended Preservice Training for Resource Parents. Child Welfare. 2014;93(6):45-72
White, L., Delaney, R., Pacifici, C., Nelson, C., Whitkin, J., Lovejoy, M., & Smalley, B. K. (2014). Efficacy of Blended Preservice Training for Resource Parents. Child welfare, 93(6), 45-72.
White, Lee, et al. "Efficacy of Blended Preservice Training for Resource Parents." Child welfare vol. 93,6 (2014): 45-72.
White L, Delaney R, Pacifici C, Nelson C, Whitkin J, Lovejoy M, Smalley BK. Efficacy of Blended Preservice Training for Resource Parents. Child Welfare. 2014 Nov-Dec;93(6):45-72. PMID: 28626240; PMCID: PMC5471628.
Copy Download .nbib Format: NLM
Unknown Effects of Breast Enhancer Products on Diagnostic Imaging Outcomes.

The journal of breast health

Pacifici S, De La Camara Egea MA, Ibarra AS.
PMID: 28331732
J Breast Health. 2016 Jan 01;12(1):50-51. doi: 10.5152/tjbh.2015.2805. eCollection 2016 Jan.

No abstract available.

Cite
Pacifici S, De La Camara Egea MA, Ibarra AS. Unknown Effects of Breast Enhancer Products on Diagnostic Imaging Outcomes. J Breast Health. 2016;12(1):50-51doi: 10.5152/tjbh.2015.2805.
Pacifici, S., De La Camara Egea, M. A., & Ibarra, A. S. (2016). Unknown Effects of Breast Enhancer Products on Diagnostic Imaging Outcomes. The journal of breast health, 12(1), 50-51. https://doi.org/10.5152/tjbh.2015.2805
Pacifici, Stefano, et al. "Unknown Effects of Breast Enhancer Products on Diagnostic Imaging Outcomes." The journal of breast health vol. 12,1 (2016): 50-51. doi: https://doi.org/10.5152/tjbh.2015.2805
Pacifici S, De La Camara Egea MA, Ibarra AS. Unknown Effects of Breast Enhancer Products on Diagnostic Imaging Outcomes. J Breast Health. 2016 Jan 01;12(1):50-51. doi: 10.5152/tjbh.2015.2805. eCollection 2016 Jan. PMID: 28331732; PMCID: PMC5351436.
Copy Download .nbib Format: NLM
Clinical Management of a Peri-Implant Giant Cell Granuloma.

Case reports in dentistry

Pacifici A, Carbone D, Marini R, Sfasciotti GL, Pacifici L.
PMID: 26788379
Case Rep Dent. 2015;2015:976756. doi: 10.1155/2015/976756. Epub 2015 Dec 14.

Purpose. Implant therapy plays an important role in contemporary dentistry with high rates of long-term success. However, in recent years, the incidence of peri-implantitis and implant failures has significantly increased. The peripheral giant cell granuloma (PGCG) rarely occurs in...

Cite
Pacifici A, Carbone D, Marini R, et al. Clinical Management of a Peri-Implant Giant Cell Granuloma. Case Rep Dent. 2015;2015:976756doi: 10.1155/2015/976756.
Pacifici, A., Carbone, D., Marini, R., Sfasciotti, G. L., & Pacifici, L. (2015). Clinical Management of a Peri-Implant Giant Cell Granuloma. Case reports in dentistry, 2015976756. https://doi.org/10.1155/2015/976756
Pacifici, A, et al. "Clinical Management of a Peri-Implant Giant Cell Granuloma." Case reports in dentistry vol. 2015 (2015): 976756. doi: https://doi.org/10.1155/2015/976756
Pacifici A, Carbone D, Marini R, Sfasciotti GL, Pacifici L. Clinical Management of a Peri-Implant Giant Cell Granuloma. Case Rep Dent. 2015;2015:976756. doi: 10.1155/2015/976756. Epub 2015 Dec 14. PMID: 26788379; PMCID: PMC4691601.
Copy Download .nbib Format: NLM
Enhanced radiative emission rate and quantum efficiency in coupled silicon nanocrystal-nanostructured gold emitters.

Nano letters

Biteen JS, Pacifici D, Lewis NS, Atwater HA.
PMID: 16159221
Nano Lett. 2005 Sep;5(9):1768-73. doi: 10.1021/nl051207z.

We report local-field-enhanced light emission from silicon nanocrystals close to a film of nanoporous gold. We resolve photoluminescence as the gold-Si nanocrystal separation distance is varied between 0 and 20 nm and observe a fourfold luminescence intensity enhancement concomitant...

Cite
Biteen JS, Pacifici D, Lewis NS, et al. Enhanced radiative emission rate and quantum efficiency in coupled silicon nanocrystal-nanostructured gold emitters. Nano Lett. 2005;5(9):1768-73doi: 10.1021/nl051207z.
Biteen, J. S., Pacifici, D., Lewis, N. S., & Atwater, H. A. (2005). Enhanced radiative emission rate and quantum efficiency in coupled silicon nanocrystal-nanostructured gold emitters. Nano letters, 5(9), 1768-73. https://doi.org/10.1021/nl051207z
Biteen, Julie S, et al. "Enhanced radiative emission rate and quantum efficiency in coupled silicon nanocrystal-nanostructured gold emitters." Nano letters vol. 5,9 (2005): 1768-73. doi: https://doi.org/10.1021/nl051207z
Biteen JS, Pacifici D, Lewis NS, Atwater HA. Enhanced radiative emission rate and quantum efficiency in coupled silicon nanocrystal-nanostructured gold emitters. Nano Lett. 2005 Sep;5(9):1768-73. doi: 10.1021/nl051207z. PMID: 16159221.
Copy Download .nbib Format: NLM
Pharmacokinetics of memantine in rats and mice.

PLoS currents

Beconi MG, Howland D, Park L, Lyons K, Giuliano J, Dominguez C, Munoz-Sanjuan I, Pacifici R.
PMID: 22307216
PLoS Curr. 2011 Dec 15;3:RRN1291. doi: 10.1371/currents.RRN1291.

To evaluate the potential of memantine as a therapeutic agent for Huntington's disease (HD) we have undertaken a series of in vitro, ex vivo and whole animal studies to characterize its pharmacokinetics (PK) and pharmacodynamics (PD) in rats and...

Cite
Beconi MG, Howland D, Park L, et al. Pharmacokinetics of memantine in rats and mice. PLoS Curr. 2011;3:RRN1291doi: 10.1371/currents.RRN1291.
Beconi, M. G., Howland, D., Park, L., Lyons, K., Giuliano, J., Dominguez, C., Munoz-Sanjuan, I., & Pacifici, R. (2011). Pharmacokinetics of memantine in rats and mice. PLoS currents, 3RRN1291. https://doi.org/10.1371/currents.RRN1291
Beconi, Maria G, et al. "Pharmacokinetics of memantine in rats and mice." PLoS currents vol. 3 (2011): RRN1291. doi: https://doi.org/10.1371/currents.RRN1291
Beconi MG, Howland D, Park L, Lyons K, Giuliano J, Dominguez C, Munoz-Sanjuan I, Pacifici R. Pharmacokinetics of memantine in rats and mice. PLoS Curr. 2011 Dec 15;3:RRN1291. doi: 10.1371/currents.RRN1291. PMID: 22307216; PMCID: PMC3269340.
Copy Download .nbib Format: NLM
Two stage surgery in IV Class of Misch with SIS device: a case report.

ORAL & implantology

Grandi C, Pacifici L.
PMID: 23285349
Oral Implantol (Rome). 2008 Oct;1(3):131-6. Epub 2009 Apr 20.

In IV Class of Misch classification is usually not possible insert fixtures at the same time of the sinus lift procedure. To solve all these situation the use of several appliances have been proposed. Among those the S.I.S. titan...

Cite
Grandi C, Pacifici L. Two stage surgery in IV Class of Misch with SIS device: a case report. Oral Implantol (Rome). 2009;1(3):131-6
Grandi, C., & Pacifici, L. (2008). Two stage surgery in IV Class of Misch with SIS device: a case report. ORAL & implantology, 1(3), 131-6.
Grandi, C, and Pacifici, L. "Two stage surgery in IV Class of Misch with SIS device: a case report." ORAL & implantology vol. 1,3 (2008): 131-6.
Grandi C, Pacifici L. Two stage surgery in IV Class of Misch with SIS device: a case report. Oral Implantol (Rome). 2008 Oct;1(3):131-6. Epub 2009 Apr 20. PMID: 23285349; PMCID: PMC3486717.
Copy Download .nbib Format: NLM
Web-Enhanced Preservice Training for Prospective Resource Parents: A Randomized Trial of Effectiveness and User Satisfaction.

Journal of social service research

Delaney R, Nelson C, Pacifici C, White L, Smalley BK.
PMID: 23019382
J Soc Serv Res. 2012;38(4):503-514. doi: 10.1080/01488376.2012.696416. Epub 2012 Jun 20.

Traditionally, prospective resource parents must attend all preservice training in person. While live sessions are necessary for activities such as screening applicants, instructional portions of training could be enhanced by web-based sessions. This pilot study compares the effectiveness of...

Cite
Delaney R, Nelson C, Pacifici C, et al. Web-Enhanced Preservice Training for Prospective Resource Parents: A Randomized Trial of Effectiveness and User Satisfaction. J Soc Serv Res. 2012;38(4):503-514doi: 10.1080/01488376.2012.696416.
Delaney, R., Nelson, C., Pacifici, C., White, L., & Smalley, B. K. (2012). Web-Enhanced Preservice Training for Prospective Resource Parents: A Randomized Trial of Effectiveness and User Satisfaction. Journal of social service research, 38(4), 503-514. https://doi.org/10.1080/01488376.2012.696416
Delaney, Richard, et al. "Web-Enhanced Preservice Training for Prospective Resource Parents: A Randomized Trial of Effectiveness and User Satisfaction." Journal of social service research vol. 38,4 (2012): 503-514. doi: https://doi.org/10.1080/01488376.2012.696416
Delaney R, Nelson C, Pacifici C, White L, Smalley BK. Web-Enhanced Preservice Training for Prospective Resource Parents: A Randomized Trial of Effectiveness and User Satisfaction. J Soc Serv Res. 2012;38(4):503-514. doi: 10.1080/01488376.2012.696416. Epub 2012 Jun 20. PMID: 23019382; PMCID: PMC3454502.
Copy Download .nbib Format: NLM
IART (Intra-Operative Avidination for Radionuclide Therapy) for accelerated radiotherapy in breast cancer patients. Technical aspects and preliminary results of a phase II study with 90Y-labelled biotin.

Ecancermedicalscience

Paganelli G, De Cicco C, Ferrari ME, McVie G, Pagani G, Leonardi MC, Cremonesi M, Ferrari A, Pacifici M, Di Dia A, Botta F, De Santis R, Galimberti V, Luini A, Orecchia R, Veronesi U.
PMID: 22276027
Ecancermedicalscience. 2010;4:166. doi: 10.3332/ecancer.2010.166. Epub 2010 Nov 01.

BACKGROUND: Breast conserving surgery (BCS) plus external beam radiotherapy (EBRT) is considered the standard treatment for early breast cancer. We have investigated the possibility of irradiating the residual gland, using an innovative nuclear medicine approach named IART(®) (Intra-operative Avidination...

Cite
Paganelli G, De Cicco C, Ferrari ME, et al. IART (Intra-Operative Avidination for Radionuclide Therapy) for accelerated radiotherapy in breast cancer patients. Technical aspects and preliminary results of a phase II study with 90Y-labelled biotin. Ecancermedicalscience. 2010;4:166doi: 10.3332/ecancer.2010.166.
Paganelli, G., De Cicco, C., Ferrari, M. E., McVie, G., Pagani, G., Leonardi, M. C., Cremonesi, M., Ferrari, A., Pacifici, M., Di Dia, A., Botta, F., De Santis, R., Galimberti, V., Luini, A., Orecchia, R., & Veronesi, U. (2010). IART (Intra-Operative Avidination for Radionuclide Therapy) for accelerated radiotherapy in breast cancer patients. Technical aspects and preliminary results of a phase II study with 90Y-labelled biotin. Ecancermedicalscience, 4166. https://doi.org/10.3332/ecancer.2010.166
Paganelli, G, et al. "IART (Intra-Operative Avidination for Radionuclide Therapy) for accelerated radiotherapy in breast cancer patients. Technical aspects and preliminary results of a phase II study with 90Y-labelled biotin." Ecancermedicalscience vol. 4 (2010): 166. doi: https://doi.org/10.3332/ecancer.2010.166
Paganelli G, De Cicco C, Ferrari ME, McVie G, Pagani G, Leonardi MC, Cremonesi M, Ferrari A, Pacifici M, Di Dia A, Botta F, De Santis R, Galimberti V, Luini A, Orecchia R, Veronesi U. IART (Intra-Operative Avidination for Radionuclide Therapy) for accelerated radiotherapy in breast cancer patients. Technical aspects and preliminary results of a phase II study with 90Y-labelled biotin. Ecancermedicalscience. 2010;4:166. doi: 10.3332/ecancer.2010.166. Epub 2010 Nov 01. PMID: 22276027; PMCID: PMC3234029.
Copy Download .nbib Format: NLM
A high-level ab initio study of the N2 + N2 reaction channel.

Journal of computational chemistry

Pacifici L, Verdicchio M, Lago NF, Lombardi A, Costantini A.
PMID: 24037708
J Comput Chem. 2013 Dec 05;34(31):2668-76. doi: 10.1002/jcc.23415. Epub 2013 Aug 26.

A new six-dimensional (6D) global potential energy surface (PES) is proposed for the full range description of the interaction of the N2(1Σg+)+N2(1Σg+) system governing collisional processes, including N atom exchange. The related potential energy values were determined using high-level...

Cite
Pacifici L, Verdicchio M, Lago NF, et al. A high-level ab initio study of the N2 + N2 reaction channel. J Comput Chem. 2013;34(31):2668-76doi: 10.1002/jcc.23415.
Pacifici, L., Verdicchio, M., Lago, N. F., Lombardi, A., & Costantini, A. (2013). A high-level ab initio study of the N2 + N2 reaction channel. Journal of computational chemistry, 34(31), 2668-76. https://doi.org/10.1002/jcc.23415
Pacifici, Leonardo, et al. "A high-level ab initio study of the N2 + N2 reaction channel." Journal of computational chemistry vol. 34,31 (2013): 2668-76. doi: https://doi.org/10.1002/jcc.23415
Pacifici L, Verdicchio M, Lago NF, Lombardi A, Costantini A. A high-level ab initio study of the N2 + N2 reaction channel. J Comput Chem. 2013 Dec 05;34(31):2668-76. doi: 10.1002/jcc.23415. Epub 2013 Aug 26. PMID: 24037708.
Copy Download .nbib Format: NLM
Hereditary multiple exostoses: are there new plausible treatment strategies?.

Expert opinion on orphan drugs

Pacifici M.
PMID: 31448184
Expert Opin Orphan Drugs. 2018;6(6):385-391. doi: 10.1080/21678707.2018.1483232. Epub 2018 Jun 07.

INTRODUCTION: Hereditary multiple exostoses (HME) is a rare congenital pediatric disorder characterized by osteochondromas forming next to the growth plates in young patients. The osteochondromas cause multiple health problems that include skeletal deformities and chronic pain. Surgery is used...

Cite
Pacifici M. Hereditary multiple exostoses: are there new plausible treatment strategies?. Expert Opin Orphan Drugs. 2018;6(6):385-391doi: 10.1080/21678707.2018.1483232.
Pacifici, M. (2018). Hereditary multiple exostoses: are there new plausible treatment strategies?. Expert opinion on orphan drugs, 6(6), 385-391. https://doi.org/10.1080/21678707.2018.1483232
Pacifici, Maurizio. "Hereditary multiple exostoses: are there new plausible treatment strategies?." Expert opinion on orphan drugs vol. 6,6 (2018): 385-391. doi: https://doi.org/10.1080/21678707.2018.1483232
Pacifici M. Hereditary multiple exostoses: are there new plausible treatment strategies?. Expert Opin Orphan Drugs. 2018;6(6):385-391. doi: 10.1080/21678707.2018.1483232. Epub 2018 Jun 07. PMID: 31448184; PMCID: PMC6707746.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 108 entries